ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Virus Vaccine (H1N1) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-23N7548
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Influenza Virus Vaccine H1N1 Market Insights and Forecast to 2028
BUY CHAPTERS

Global Influenza Virus Vaccine (H1N1) Market Research Report 2025

Code: QYRE-Auto-23N7548
Report
July 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
NVS(Novartis)
Sanofi Pasteur
MedImmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm

Influenza Virus Vaccine (H1N1) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Influenza Virus Vaccine (H1N1) Market

Influenza Virus Vaccine (H1N1) Market

The global market for Influenza Virus Vaccine (H1N1) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Influenza Virus Vaccine (H1N1), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Virus Vaccine (H1N1).
The Influenza Virus Vaccine (H1N1) market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Influenza Virus Vaccine (H1N1) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Virus Vaccine (H1N1) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Influenza Virus Vaccine (H1N1) Market Report

Report Metric Details
Report Name Influenza Virus Vaccine (H1N1) Market
CAGR 5%
Segment by Type
Segment by Application
  • 3 To 10 Years Old
  • 10 To 18 Years Old
  • Above 18 Years Old
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL, NVS(Novartis), Sanofi Pasteur, Medimmune, GSK, Baxter, Beijing Kexing Bio-Vaccine, Hualan Bio-Vaccine, Changchun Changsheng Bio-Technology, Beijing Tiantan Bio-Products, Jiangsu Yanshen Bio-Technology, Zhejiang Tianyuan Bio-Pharmaceutical, Dalian Yalifeng Bio-Pharmaceutical, Sinopharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Influenza Virus Vaccine (H1N1) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Influenza Virus Vaccine (H1N1) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Influenza Virus Vaccine (H1N1) Market report?

Ans: The main players in the Influenza Virus Vaccine (H1N1) Market are CSL, NVS(Novartis), Sanofi Pasteur, Medimmune, GSK, Baxter, Beijing Kexing Bio-Vaccine, Hualan Bio-Vaccine, Changchun Changsheng Bio-Technology, Beijing Tiantan Bio-Products, Jiangsu Yanshen Bio-Technology, Zhejiang Tianyuan Bio-Pharmaceutical, Dalian Yalifeng Bio-Pharmaceutical, Sinopharm

What are the Application segmentation covered in the Influenza Virus Vaccine (H1N1) Market report?

Ans: The Applications covered in the Influenza Virus Vaccine (H1N1) Market report are 3 To 10 Years Old, 10 To 18 Years Old, Above 18 Years Old, Other

What are the Type segmentation covered in the Influenza Virus Vaccine (H1N1) Market report?

Ans: The Types covered in the Influenza Virus Vaccine (H1N1) Market report are Intramuscular Vaccine, Nasal Spray Vaccine

Recommended Reports

Influenza Vaccines

Vaccine Technology

Vaccine Infrastructure

1 Influenza Virus Vaccine (H1N1) Market Overview
1.1 Product Definition
1.2 Influenza Virus Vaccine (H1N1) by Type
1.2.1 Global Influenza Virus Vaccine (H1N1) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Influenza Virus Vaccine (H1N1) by Application
1.3.1 Global Influenza Virus Vaccine (H1N1) Market Value by Application (2024 VS 2031)
1.3.2 3 To 10 Years Old
1.3.3 10 To 18 Years Old
1.3.4 Above 18 Years Old
1.3.5 Other
1.4 Global Influenza Virus Vaccine (H1N1) Market Size Estimates and Forecasts
1.4.1 Global Influenza Virus Vaccine (H1N1) Revenue 2020-2031
1.4.2 Global Influenza Virus Vaccine (H1N1) Sales 2020-2031
1.4.3 Global Influenza Virus Vaccine (H1N1) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Influenza Virus Vaccine (H1N1) Market Competition by Manufacturers
2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Influenza Virus Vaccine (H1N1), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Product Type & Application
2.7 Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Date of Enter into This Industry
2.8 Global Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends
2.8.1 Global Influenza Virus Vaccine (H1N1) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Influenza Virus Vaccine (H1N1) Players Market Share by Revenue
2.8.3 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Influenza Virus Vaccine (H1N1) Market Scenario by Region
3.1 Global Influenza Virus Vaccine (H1N1) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Influenza Virus Vaccine (H1N1) Sales by Region: 2020-2031
3.2.1 Global Influenza Virus Vaccine (H1N1) Sales by Region: 2020-2025
3.2.2 Global Influenza Virus Vaccine (H1N1) Sales by Region: 2026-2031
3.3 Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2020-2031
3.3.1 Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2020-2025
3.3.2 Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2026-2031
3.4 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.4.1 North America Influenza Virus Vaccine (H1N1) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Influenza Virus Vaccine (H1N1) Sales by Country (2020-2031)
3.4.3 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.5.1 Europe Influenza Virus Vaccine (H1N1) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2020-2031)
3.5.3 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region
3.6.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2020-2031)
3.6.3 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.7.1 Latin America Influenza Virus Vaccine (H1N1) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2020-2031)
3.7.3 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2020-2031)
4.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2020-2025)
4.1.2 Global Influenza Virus Vaccine (H1N1) Sales by Type (2026-2031)
4.1.3 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2020-2031)
4.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2020-2031)
4.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2020-2025)
4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2026-2031)
4.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2020-2031)
4.3 Global Influenza Virus Vaccine (H1N1) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2020-2031)
5.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2020-2025)
5.1.2 Global Influenza Virus Vaccine (H1N1) Sales by Application (2026-2031)
5.1.3 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2020-2031)
5.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2020-2031)
5.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2020-2025)
5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2026-2031)
5.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2020-2031)
5.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Company Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Influenza Virus Vaccine (H1N1) Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 NVS(Novartis)
6.2.1 NVS(Novartis) Company Information
6.2.2 NVS(Novartis) Description and Business Overview
6.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Portfolio
6.2.5 NVS(Novartis) Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Company Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Medimmune
6.4.1 Medimmune Company Information
6.4.2 Medimmune Description and Business Overview
6.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Medimmune Influenza Virus Vaccine (H1N1) Product Portfolio
6.4.5 Medimmune Recent Developments/Updates
6.5 GSK
6.5.1 GSK Company Information
6.5.2 GSK Description and Business Overview
6.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GSK Influenza Virus Vaccine (H1N1) Product Portfolio
6.5.5 GSK Recent Developments/Updates
6.6 Baxter
6.6.1 Baxter Company Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Baxter Influenza Virus Vaccine (H1N1) Product Portfolio
6.6.5 Baxter Recent Developments/Updates
6.7 Beijing Kexing Bio-Vaccine
6.7.1 Beijing Kexing Bio-Vaccine Company Information
6.7.2 Beijing Kexing Bio-Vaccine Description and Business Overview
6.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolio
6.7.5 Beijing Kexing Bio-Vaccine Recent Developments/Updates
6.8 Hualan Bio-Vaccine
6.8.1 Hualan Bio-Vaccine Company Information
6.8.2 Hualan Bio-Vaccine Description and Business Overview
6.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolio
6.8.5 Hualan Bio-Vaccine Recent Developments/Updates
6.9 Changchun Changsheng Bio-Technology
6.9.1 Changchun Changsheng Bio-Technology Company Information
6.9.2 Changchun Changsheng Bio-Technology Description and Business Overview
6.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolio
6.9.5 Changchun Changsheng Bio-Technology Recent Developments/Updates
6.10 Beijing Tiantan Bio-Products
6.10.1 Beijing Tiantan Bio-Products Company Information
6.10.2 Beijing Tiantan Bio-Products Description and Business Overview
6.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Portfolio
6.10.5 Beijing Tiantan Bio-Products Recent Developments/Updates
6.11 Jiangsu Yanshen Bio-Technology
6.11.1 Jiangsu Yanshen Bio-Technology Company Information
6.11.2 Jiangsu Yanshen Bio-Technology Description and Business Overview
6.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolio
6.11.5 Jiangsu Yanshen Bio-Technology Recent Developments/Updates
6.12 Zhejiang Tianyuan Bio-Pharmaceutical
6.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
6.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolio
6.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates
6.13 Dalian Yalifeng Bio-Pharmaceutical
6.13.1 Dalian Yalifeng Bio-Pharmaceutical Company Information
6.13.2 Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
6.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolio
6.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Developments/Updates
6.14 Sinopharm
6.14.1 Sinopharm Company Information
6.14.2 Sinopharm Description and Business Overview
6.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Product Portfolio
6.14.5 Sinopharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Virus Vaccine (H1N1) Industry Chain Analysis
7.2 Influenza Virus Vaccine (H1N1) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Virus Vaccine (H1N1) Production Mode & Process Analysis
7.4 Influenza Virus Vaccine (H1N1) Sales and Marketing
7.4.1 Influenza Virus Vaccine (H1N1) Sales Channels
7.4.2 Influenza Virus Vaccine (H1N1) Distributors
7.5 Influenza Virus Vaccine (H1N1) Customer Analysis
8 Influenza Virus Vaccine (H1N1) Market Dynamics
8.1 Influenza Virus Vaccine (H1N1) Industry Trends
8.2 Influenza Virus Vaccine (H1N1) Market Drivers
8.3 Influenza Virus Vaccine (H1N1) Market Challenges
8.4 Influenza Virus Vaccine (H1N1) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Limited
NVS(Novartis)
Sanofi Pasteur
MedImmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm
List of Tables
 Table 1. Global Influenza Virus Vaccine (H1N1) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Influenza Virus Vaccine (H1N1) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Influenza Virus Vaccine (H1N1) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Influenza Virus Vaccine (H1N1), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Product Type & Application
 Table 12. Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Influenza Virus Vaccine (H1N1) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Influenza Virus Vaccine (H1N1) Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2020-2025)
 Table 19. Global Influenza Virus Vaccine (H1N1) Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2026-2031)
 Table 21. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2020-2025)
 Table 23. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2026-2031)
 Table 25. North America Influenza Virus Vaccine (H1N1) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Influenza Virus Vaccine (H1N1) Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Influenza Virus Vaccine (H1N1) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2020-2025)
 Table 51. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2026-2031)
 Table 52. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2020-2025)
 Table 53. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2026-2031)
 Table 54. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2020-2025)
 Table 57. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2026-2031)
 Table 58. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2020-2025)
 Table 61. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2026-2031)
 Table 62. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2020-2025)
 Table 63. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2026-2031)
 Table 64. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2020-2025)
 Table 67. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2026-2031)
 Table 68. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2026-2031)
 Table 70. CSL Company Information
 Table 71. CSL Description and Business Overview
 Table 72. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. CSL Influenza Virus Vaccine (H1N1) Product
 Table 74. CSL Recent Developments/Updates
 Table 75. NVS(Novartis) Company Information
 Table 76. NVS(Novartis) Description and Business Overview
 Table 77. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product
 Table 79. NVS(Novartis) Recent Developments/Updates
 Table 80. Sanofi Pasteur Company Information
 Table 81. Sanofi Pasteur Description and Business Overview
 Table 82. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product
 Table 84. Sanofi Pasteur Recent Developments/Updates
 Table 85. Medimmune Company Information
 Table 86. Medimmune Description and Business Overview
 Table 87. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Medimmune Influenza Virus Vaccine (H1N1) Product
 Table 89. Medimmune Recent Developments/Updates
 Table 90. GSK Company Information
 Table 91. GSK Description and Business Overview
 Table 92. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. GSK Influenza Virus Vaccine (H1N1) Product
 Table 94. GSK Recent Developments/Updates
 Table 95. Baxter Company Information
 Table 96. Baxter Description and Business Overview
 Table 97. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Baxter Influenza Virus Vaccine (H1N1) Product
 Table 99. Baxter Recent Developments/Updates
 Table 100. Beijing Kexing Bio-Vaccine Company Information
 Table 101. Beijing Kexing Bio-Vaccine Description and Business Overview
 Table 102. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
 Table 104. Beijing Kexing Bio-Vaccine Recent Developments/Updates
 Table 105. Hualan Bio-Vaccine Company Information
 Table 106. Hualan Bio-Vaccine Description and Business Overview
 Table 107. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
 Table 109. Hualan Bio-Vaccine Recent Developments/Updates
 Table 110. Changchun Changsheng Bio-Technology Company Information
 Table 111. Changchun Changsheng Bio-Technology Description and Business Overview
 Table 112. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product
 Table 114. Changchun Changsheng Bio-Technology Recent Developments/Updates
 Table 115. Beijing Tiantan Bio-Products Company Information
 Table 116. Beijing Tiantan Bio-Products Description and Business Overview
 Table 117. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product
 Table 119. Beijing Tiantan Bio-Products Recent Developments/Updates
 Table 120. Jiangsu Yanshen Bio-Technology Company Information
 Table 121. Jiangsu Yanshen Bio-Technology Description and Business Overview
 Table 122. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product
 Table 124. Jiangsu Yanshen Bio-Technology Recent Developments/Updates
 Table 125. Zhejiang Tianyuan Bio-Pharmaceutical Company Information
 Table 126. Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
 Table 127. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
 Table 129. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates
 Table 130. Dalian Yalifeng Bio-Pharmaceutical Company Information
 Table 131. Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
 Table 132. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 133. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
 Table 134. Dalian Yalifeng Bio-Pharmaceutical Recent Developments/Updates
 Table 135. Sinopharm Company Information
 Table 136. Sinopharm Description and Business Overview
 Table 137. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 138. Sinopharm Influenza Virus Vaccine (H1N1) Product
 Table 139. Sinopharm Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Influenza Virus Vaccine (H1N1) Distributors List
 Table 143. Influenza Virus Vaccine (H1N1) Customers List
 Table 144. Influenza Virus Vaccine (H1N1) Market Trends
 Table 145. Influenza Virus Vaccine (H1N1) Market Drivers
 Table 146. Influenza Virus Vaccine (H1N1) Market Challenges
 Table 147. Influenza Virus Vaccine (H1N1) Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Influenza Virus Vaccine (H1N1)
 Figure 2. Global Influenza Virus Vaccine (H1N1) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Influenza Virus Vaccine (H1N1) Market Share by Type: 2024 & 2031
 Figure 4. Intramuscular Vaccine Product Picture
 Figure 5. Nasal Spray Vaccine Product Picture
 Figure 6. Global Influenza Virus Vaccine (H1N1) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Influenza Virus Vaccine (H1N1) Market Share by Application: 2024 & 2031
 Figure 8. 3 To 10 Years Old
 Figure 9. 10 To 18 Years Old
 Figure 10. Above 18 Years Old
 Figure 11. Other
 Figure 12. Global Influenza Virus Vaccine (H1N1) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Influenza Virus Vaccine (H1N1) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Influenza Virus Vaccine (H1N1) Sales (2020-2031) & (K Doses)
 Figure 15. Global Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) & (2020-2031)
 Figure 16. Influenza Virus Vaccine (H1N1) Report Years Considered
 Figure 17. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2024
 Figure 18. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Influenza Virus Vaccine (H1N1) Players: Market Share by Revenue in Influenza Virus Vaccine (H1N1) in 2024
 Figure 20. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Influenza Virus Vaccine (H1N1) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2020-2031)
 Figure 23. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2020-2031)
 Figure 27. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2020-2031)
 Figure 35. China Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Influenza Virus Vaccine (H1N1) by Type (2020-2031)
 Figure 57. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Influenza Virus Vaccine (H1N1) by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Influenza Virus Vaccine (H1N1) by Application (2020-2031)
 Figure 60. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2020-2031)
 Figure 61. Influenza Virus Vaccine (H1N1) Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Animal Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Virus Vector Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Viral Disease Vaccines Market Research Report 2024
Global mRNA Flu Vaccine Market Research Report 2024
Split Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza Virus Kits Market Research Report 2024
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Container Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Needle Free Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Norovirus Vaccine Market Research Report 2024
Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cell based Flu Vaccine Market
Rabies Virus Vaccine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Daignostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
General Influenza Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inactivated Influenza Virus Vaccine Market Research Report 2025
Global Respiratory Virus Vaccines Market Research Report 2024
Global Vaccine for Influenza Market Research Report 2025
Global Influenza Drugs and Vaccines Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions